Press "Enter" to skip to content

Trovagene’s Onvansertib Shows Response in Phase Ib AML Study – Yahoo Finance

admin 0

Trovagene’s Onvansertib Shows Response in Phase Ib AML Study  Yahoo Finance

Trovagene (TROV) successfully completes a phase Ib study, evaluating onvansertib in combination with standard-of-care in AML patients. The regimen is well …

“colorectal cancer” – Google News

(Visited 4 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *